ZENYAKU KOGYO
Zenyaku Kogyo is a privately-held Japanese pharmaceutical company with headquarters in Tokyo. The company is marketing in Japan dermatological and anti-cancer drugs including RituxanTM, an anti-CD20 antibody for the treatment of B-cell Non-Hodgkin’s Lymphoma. The company also has an OTC consumer health care business. Zenyaku Kogyo’s ongoing research interests are focused on cancer, autoimmune diseases, and antibody therapeutics.
ZENYAKU KOGYO
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
1950-01-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.zenyaku.co.jp
Status:
Active
Contact:
81 3 3946 1111
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Apache Euro Microsoft Exchange Online Amazon Office 365 Mail
Similar Organizations
Link Health Group
Link Health Group is a leading Chinese pharmaceutical company
Seren Pharmaceuticals
Seren Pharma Co., Ltd. is a clinical development-specific pharmaceutical company.
Takeda Oncology
Takeda Oncology is a leading biopharmaceutical company.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-09-30 | Repertoire Genesis | Zenyaku Kogyo investment in Corporate Round - Repertoire Genesis | 798 M JPY |
| 2016-12-05 | Kringle Pharma | Zenyaku Kogyo investment in Venture Round - Kringle Pharma | 610 M JPY |
| 2013-03-25 | Theraclone Sciences | Zenyaku Kogyo investment in Series B - Theraclone Sciences | 8 M USD |
| 2011-09-08 | Theraclone Sciences | Zenyaku Kogyo investment in Series B - Theraclone Sciences | 10.6 M USD |
| 2007-12-04 | Kringle Pharma | Zenyaku Kogyo investment in Venture Round - Kringle Pharma | 1.06 B JPY |
Official Site Inspections
http://www.zenyaku.co.jp Semrush global rank: 284.11 K Semrush visits lastest month: 230.73 K
- Host name: ec2-18-182-123-18.ap-northeast-1.compute.amazonaws.com
- IP address: 18.182.123.18
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
Loading ... 